Biopharmaceutical Stocks List

Biopharmaceutical Stocks Recent News

Date Stock Title
Apr 25 AZN Top Midday Stories: Shares of Meta, IBM, Caterpillar, Comcast and Southwest Down Big Post-Earnings; AstraZeneca Shares See Post-Earnings Bump
Apr 25 AZN AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
Apr 25 AZN AstraZeneca reinforcing supply chain amid global tensions: CEO
Apr 25 AZN 20 Fastest Growing Health Tech Companies in the World
Apr 25 AZN Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up
Apr 25 AZN AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
Apr 25 AZN AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
Apr 25 AZN Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say
Apr 25 AZN Cancer drugs help drive AstraZeneca sales sharply higher
Apr 25 AZN AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 25 AZN Trending tickers: Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's
Apr 25 AZN AstraZeneca Earnings, Sales Rise, Beat Forecasts
Apr 25 AZN UPDATE 2-AstraZeneca trounces first-quarter estimates as resilient demand fuels growth
Apr 25 AZN AstraZeneca leaps after smashing first quarter forecasts
Apr 25 AZN Q1 2024 results
Apr 24 AZN Alphabet, Microsoft, Southwest earnings: What to watch
Apr 23 AZN AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Apr 22 AZN With 85% ownership, AstraZeneca PLC (LON:AZN) boasts of strong institutional backing
Apr 22 AZN Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics
Apr 21 AZN 11 Best Low Price Pharma Stocks To Invest In
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.
Terminology surrounding biopharmaceuticals varies between groups and entities, with different terms referring to different subsets of therapeutics within the general biopharmaceutical category. Some regulatory agencies use the terms biological medicinal products or therapeutic biological product to refer specifically to engineered macromolecular products like protein- and nucleic acid-based drugs, distinguishing them from products like blood, blood components, or vaccines, which are usually extracted directly from a biological source. Specialty drugs, a recent classification of pharmaceuticals, are high-cost drugs that are often biologics. The European Medicines Agency uses the term advanced therapy medicinal products (ATMPs) for medicines for human use that are "based on genes, cells, or tissue engineering", including gene therapy medicines, somatic-cell therapy medicines, tissue-engineered medicines, and combinations thereof. Within EMA contexts, the term advanced therapies refers specifically to ATMPs, although that term is rather nonspecific outside those contexts.
Gene-based and cellular biologics, for example, often are at the forefront of biomedical research, and may be used to treat a variety of medical conditions for which no other treatments are available.In some jurisdictions, biologics are regulated via different pathways than other small molecule drugs and medical devices.The term biopharmacology is sometimes used to describe the branch of pharmacology that studies biopharmaceuticals.

Browse All Tags